TY - JOUR
T1 - Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial
JO - SKIN The Journal of Cutaneous Medicine
UR - http://dx.doi.org/10.25251/skin.7.supp.140
PY - 2023/03/13
AU - Wollenberg A
AU - Cork M
AU - Flohr C
AU - Bewley A
AU - Blauvelt A
AU - Hong C-H
AU - Imafuku S
AU - Schuttelaar MLA
AU - Simpson E
AU - Soong W
AU - Amoudruz P et al
ED -
DO - DOI: 10.25251/skin.7.supp.140
PB - National Society for Cutaneous Medicine
VL - 7
IS - 2
SP - s140
EP - s140
Y2 - 2025/07/17
ER -